img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$9,199,167

Follow-On Offering
Sole Bookrunner

May 1, 2019
img
Jiayin Group Inc
(Nasdaq: JFIN)

$36,750,000

Follow-On Offering
Co-Manager

May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$1,299,998

Private Placement
Placement Agent

May 1, 2019
img
img
Genetic Technologies
(Nasdaq: GENE)

$1,180,917


Sole Bookrunner

April 1, 2019
img
img
Monaker Group
(Nasdaq: MKGI)

$1,740,000

Follow-On Offering
Co-Manager

img
img
Golden Matrix Group Inc.
(OTCPK: GMGI)

$10,000,000

Underwritten Public Offering
Sole Bookrunner

img
img
Unicycive Therapeutics Inc.
(Nasdaq: UNCY)

Initial Public Offering
Lead Manager

1 … 32 33 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.